Merck to help produce Johnson & Johnson Covid-19 vaccine

Merck, an American multinational pharmaceutical company and one of the largest pharmaceutical companies in the world, will help produce Johnson & Johnson's one-shot Covid-19 vaccine, the company announced in a statement.

"Merck [...] announced today it has entered into multiple agreements to support efforts to expand manufacturing capacity and supply of SARS-CoV-2/COVID-19 medicines and vaccines," and will "support the manufacturing and supply of Johnson & Johnson’s SARS-CoV-2/COVID-19 vaccine," the statement reads.

“We are steadfast in our commitment to contribute to the global response to the pandemic as part of the remarkable efforts of the entire medical and scientific community,” said Mike Nally, executive vice president, Human Health at Merck. “This funding from BARDA will allow us to accelerate our efforts to scale up our manufacturing capacity to enable timely delivery of much-needed medicines and vaccines for the pandemic.”